Peptides are a broad category of molecules made from amino acids. GLP-1 is one specific peptide hormone. GLP-1 medications, such as semaglutide and liraglutide, are drugs designed to activate the GLP-1 receptor and reproduce some of the hormone's effects.
The category is broad, while GLP-1 refers to one hormone and its biological pathway. A 2025 FDA warning letter also shows why the distinction matters: compounded drug products are not FDA-approved and should not be presented as identical to FDA-approved products.
Peptides vs. GLP-1 at a Glance
| Feature | Peptides | GLP-1 |
|---|---|---|
| Meaning | A broad class of molecules made from two or more amino acids | A specific peptide hormone called glucagon-like peptide-1 |
| Scope | Includes many hormones, signaling molecules and medicines | Refers to one hormone and its biological pathway |
| Main effects | Depend on the individual peptide | Helps regulate blood sugar, insulin, glucagon, digestion and appetite |
| Medical use | Varies by peptide | Provides the basis for certain diabetes and weight-management medicines |
| Examples | Insulin, oxytocin and GLP-1 are peptide hormones | Semaglutide and liraglutide mimic or activate GLP-1 activity |
| FDA approval | The word "peptide" does not indicate approval status | Some GLP-1 receptor agonists are FDA-approved for specific conditions |
What Is a Peptide?
A peptide is a molecule made from two or more amino acids, the building blocks of proteins. Peptides can act as hormones, neurotransmitters, cellular signals or medicines.
The word peptide does not identify one treatment or one health benefit. It does not tell you:
- What the substance does
- Whether it has been tested in human studies
- Whether it is FDA-approved
- Whether it is intended for weight loss, diabetes, muscle growth, skin care or another use
- How it should be dosed or administered
That makes "peptides" and GLP-1 an uneven comparison. It is similar to comparing "medications" with "aspirin." Aspirin belongs to the larger medication category, just as GLP-1 belongs to the larger peptide category.
What Is GLP-1?
GLP-1 stands for glucagon-like peptide-1. It is an incretin hormone involved in the body's response to food. GLP-1 helps stimulate insulin release when blood glucose is elevated, reduces glucagon release and can slow the movement of food through the stomach. GLP-1 signaling also affects appetite and food intake.
The body breaks down natural GLP-1 quickly. The FDA reports an approximate half-life of about two minutes for endogenous GLP-1. Medicines based on this pathway are therefore designed or modified to produce longer-lasting GLP-1 receptor activation.
What Are GLP-1 Medications?
GLP-1 medications are prescription drugs that activate the GLP-1 receptor or mimic GLP-1 activity. They are commonly called GLP-1 receptor agonists, or GLP-1 RAs.
Examples include:
- Semaglutide, used in Ozempic, Rybelsus and Wegovy for different approved indications
- Liraglutide, used in Victoza and Saxenda
- Dulaglutide, used in Trulicity
- Exenatide, used in Byetta and Bydureon
The approved use depends on the product, dose and patient population. GLP-1 medicines may be prescribed for type 2 diabetes or chronic weight management when a patient meets the relevant medical criteria.
Are GLP-1 Drugs Peptides?
Yes. Many GLP-1 medicines are peptide-based drugs, but not every product described as a "peptide" is a GLP-1 medication.
A product marketed as a peptide may target a different receptor or biological pathway. It may also have a different evidence base, regulatory status and safety profile from semaglutide or liraglutide.
Before evaluating a peptide product, find out:
- What is the exact active ingredient?
- What receptor or biological pathway does it affect?
- Has it been tested in appropriate human clinical trials?
- Is the specific product FDA-approved for the intended use?
- Is it prescribed and supplied through a legitimate healthcare channel?
GLP-1 Agonists Are Not All the Same
The term GLP-1 is often used as shorthand for several medicines, but some of those medicines act on more than one receptor.
Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, activates both the GIP receptor and the GLP-1 receptor. It is more accurately described as a dual GIP/GLP-1 receptor agonist than as a pure GLP-1 receptor agonist.
That distinction can affect how a medicine works, its approved uses and its side-effect profile.
"Peptide Therapy" Versus GLP-1 Treatment
Peptide therapy is too broad a label to show whether a treatment is effective or suitable. It may refer to an FDA-approved peptide drug, an investigational compound or a compounded product that the FDA has not reviewed for safety, effectiveness and quality.
An FDA-approved GLP-1 medication has a defined active ingredient, approved indications, prescribing information, dosing instructions and clinical evidence. A product described only as a peptide may not have the same documentation.
Compounded products can also differ in formulation, concentration, quality controls and labeling. FDA warning letters state that compounded drugs are not FDA-approved and should not be represented as identical to FDA-approved products.
Which Is Better for Weight Loss or Diabetes?
For diabetes or medically indicated weight management, an FDA-approved GLP-1-based medication is a more evidence-based option than an unspecified "peptide."
The right treatment depends on factors such as:
- The condition being treated
- Blood glucose levels and other medications
- Weight-management goals
- Kidney, gastrointestinal or pancreatic health
- Personal and family medical history
- Cost, insurance coverage and availability
- The medication's approved indication
GLP-1 medicines can cause side effects, including nausea, especially when treatment begins. They require a prescription and should be selected and monitored by a qualified healthcare professional.
The Bottom Line
The word peptide describes a type of molecule. It does not identify a particular treatment, benefit or approval status. GLP-1 refers to one peptide hormone and the medicines designed to activate its pathway.
For blood sugar control or weight management, check the exact active ingredient, its approved use and how it is being prescribed and supplied. A broad "peptide" label is not enough to assess a product.